Article Details
Retrieved on: 2021-07-06 21:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Under its terms, Alector and GlaxoSmithKline will jointly develop two monoclonal antibodies with the aim of bringing them to market. These molecules ...
Article found on: www.fool.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here